Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Top Cited Papers
- 1 November 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (18), 1810-1820
- https://doi.org/10.1056/nejmoa072252
Abstract
Advanced gastric cancer can respond to S-1, an oral fluoropyrimidine. We tested S-1 as adjuvant chemotherapy in patients with curatively resected gastric cancer.Keywords
This publication has 25 references indexed in Scilit:
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary ReportTumori Journal, 2002
- Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatmentAnnals of Surgical Oncology, 2002
- Gastric cancer treatment guidelines in JapanGastric Cancer, 2002
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trialsAnnals of Oncology, 2000
- Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trialsEuropean Journal Of Cancer, 1999
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal Of Cancer, 1998
- Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsAnti-Cancer Drugs, 1996
- Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.Journal of Clinical Oncology, 1993